Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14365/3408
Title: Design and applications of intelligent systems in identifying future occurrence of tuberculosis infection in population at risk
Authors: Ardalan A.
Selen E.S.
Dashti H.
Talaat A.
Assadi A.
Keywords: biomarkers and intelligent decision systems
early detection
Mycobacterium tuberculosis
Vapnik's statistical learning theory
Activation analysis
Biomarkers
Chemical activation
Computation theory
Decision theory
Diagnosis
Forecasting
Gene expression
Health risks
Intelligent systems
Mammals
Network security
Public health
Empirical risk minimization
Gene expression analysis
Hybrid intelligent system
Intelligent decision systems
Mycobacterium tuberculosis
Personalized healthcare
Personalized medicines
Statistical learning theory
Risk assessment
Publisher: Springer New York LLC
Abstract: Tuberculosis is a treatable but severe disease caused by Mycobacterium tuberculosis (Mtb). Recent statistics by international health organizations estimate the Mtb exposure to have reached over two billion individuals. Delay in disease diagnosis could be fatal, especially to the population at risk, such as individuals with compromised immune systems. Intelligent decision systems (IDS) provide a promising tool to expedite discovery of biomarkers, and to boost their impact on earlier prediction of the likelihood of the disease onset. A novel IDS (iTB) is designed that integrates results from molecular medicine and systems biology of Mtb infection to estimate model parameters for prediction of the dynamics of the gene networks in Mtb-infected laboratory animals. The mouse model identifies a number of genes whose expressions could be significantly altered during the TB activation. Among them, a much smaller number of the most informative genes for prediction of the onset of TB are selected using a modified version of Empirical Risk Minimization as in Vapnik's statistical learning theory. A hybrid intelligent system is designed to take as input the mRNA abundance at a near genome-size from the individual-to-be-tested, measured 3-4 times. The algorithms determine if that individual is at risk of the onset of the disease based on our current analysis of mRNA data, and to predict the values of the biomarkers for a future period (of up to 60 days for mice; this may differ for humans). An early warning sign allows conducting gene expression analysis during the activation which aims to find key genes that are expressed. With rapid advances in low-cost genome-based diagnosis, this IDS architecture provides a promising platform to advance Personalized Health Care based on sequencing the genome and microarray analysis of samples obtained from individuals at risk. The novelty of the design of iTB lies in the integration of the IDS design principles and the solution of the biological problems hand-in-hand, so as to provide an AI framework for biologically better-targeted personalized prevention/treatment for the high-risk groups. The iTB design applies in more generality, and provides the potential for extension of our AI-approach to personalized-medicine to prevent other public health pandemics. © 2011 IFIP International Federation for Information Processing.
URI: https://doi.org/10.1007/978-3-642-19170-1_13
https://hdl.handle.net/20.500.14365/3408
ISBN: 9.78364E+12
ISSN: 1868-4238
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File SizeFormat 
2516.pdf988.67 kBAdobe PDFView/Open
Show full item record



CORE Recommender

Page view(s)

70
checked on Nov 25, 2024

Download(s)

18
checked on Nov 25, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.